307 related articles for article (PubMed ID: 23576801)
1. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
[TBL] [Abstract][Full Text] [Related]
2. IL-22+ CD4+ T cells in patients with rheumatoid arthritis.
Zhao L; Jiang Z; Jiang Y; Ma N; Zhang Y; Feng L; Wang K
Int J Rheum Dis; 2013 Oct; 16(5):518-26. PubMed ID: 24164838
[TBL] [Abstract][Full Text] [Related]
3. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
4. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
Dolff S; Bijl M; Huitema MG; Limburg PC; Kallenberg CG; Abdulahad WH
Clin Immunol; 2011 Nov; 141(2):197-204. PubMed ID: 21920821
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
[TBL] [Abstract][Full Text] [Related]
6. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
8. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
11. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P
J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus.
Ouyang H; Shi Y; Liu Z; Feng S; Li L; Su N; Lu Y; Kong S
Mol Med Rep; 2013 Mar; 7(3):1031-7. PubMed ID: 23291628
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
16. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
17. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
18. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
[TBL] [Abstract][Full Text] [Related]
19. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
20. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
